Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$55,779,025
+$6,185,868 QoQ
Shares Held
221,662
-2.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
#347
of 4,176 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $128,781,101 across 17 Drug Manufacturers - General names. ABBV ranks #1 (43.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
221,662 | $55,779,025 | |
| 2 | LLY |
ELI LILLY & Co
|
27,683 | $33,203,823 | |
| 3 | JNJ |
Johnson & Johnson
|
69,981 | $17,773,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,366 | $5,187,031 | |
| 5 | PFE |
Pfizer Inc
|
141,011 | $3,395,544 | |
| 6 | AMGN |
Amgen Inc
|
8,295 | $3,003,785 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,112 | $2,887,453 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,237 | $2,809,422 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,779,025 | 221,662 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $49,593,157 | 228,025 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,308,277 | 172,035 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,886,672 | 25,424 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,604,860 | 24,808 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,188,553 | 24,764 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,079,636 | 22,958 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,379,711 | 22,178 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,965,713 | 23,121 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $4,063,197 | 22,313 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $3,318,062 | 21,411 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,767,895 | 18,569 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,977,971 | 14,681 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,334,292 | 14,647 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,336,072 | 14,455 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $3,184,937 | 23,731 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,634,639 | 23,731 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $3,043,521 | 22,478 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $8,212,250 | 76,131 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,015,029 | 80,034 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,223,746 | 75,991 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||